Quantcast

Latest Biologic Stories

2014-03-11 08:28:39

SAN ANTONIO, March 11, 2014 /PRNewswire/ -- Aperion Biologics, Inc., a clinical-stage regenerative medical device company, announced that France Dixon Helfer and Mike Ward were appointed to the Company's Board of Directors. Ms. Helfer currently serves as President and Chief Executive Officer of Halo Healthcare Inc., a medical device and diagnostics company which develops innovative technologies for early risk detection of breast cancer. Most recently, she was the founder and CEO of...

2014-03-10 08:28:58

ROCKVILLE, Md., March 10, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, announced today that the U.S. Patent & Trademark Office has issued U.S. Patent No. 8,658,627 entitled, Pregnancy Hormone Combination for Treatment of Autoimmune Diseases, to the Regents of the University of California (UCLA). The patent includes claims to...

2014-03-06 23:04:31

Catalent Pharma Solutions, the global leader in advanced delivery technologies and development solutions for drug, biologic and consumer health products, today announced an agreement with the Center for iPS Cell Research and Application (CiRA) at Kyoto University in Japan to make a major advancement toward one of the first regenerative human therapies with induced pluripotent stem (iPS) cells applicable to humans. Somerset, NJ (PRWEB) March 06, 2014 Catalent Pharma Solutions, the global...

2014-03-06 12:27:36

LONDON, March 6, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Biotechnology Products Markets in China China's demand for biotechnology products has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major...

2014-03-06 12:26:44

DUBLIN, Mar. 06, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/njgf7d/research_report ) has announced the addition of the "Concise Analysis of the International and China Monoclonal Antibody Industry" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Monoclonal antibody still belongs to high-end products in China market, which mainly depends on import. In 2012, the market scale of monoclonal antibody was only over...

2014-03-05 08:28:30

ROCKVILLE, Md., March 5, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, announced today that Jeffrey Riley, CEO, is scheduled to present at the 26th Annual ROTH Conference being held on March 9-12, 2014 at the Ritz-Carlton, Laguna Niguel in Dana Point, CA. Mr. Riley is scheduled to present on Tuesday, March 11, 2014 at 2:00 p.m....

2014-03-04 08:30:51

BEIJING, March 4, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release fourth quarter and fiscal year 2013 financial results on Wednesday, March 12, 2014 after the market closes. The Company's management will hold a conference call at 8:00 a.m. ET on Thursday, March 13, 2014, which is 8:00 p.m., Beijing Time on...

2014-03-03 08:30:54

PETACH TIKVA, Israel, March 3, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the addition of a key opinion leader, medical and industry expert, Dr. Lee S. Simon, as consultant to assist in the regulatory and clinical development of the company's CF101 rheumatoid arthritis program. The need to bring Dr. Simon on board...

2014-02-27 23:27:06

Selexis CSO Demonstrates How the Selexis SURE CHO-Mplus™ Libraries Can Dramatically Improve Biologic Protein Expression in Mammalian Cell Lines Geneva, Switzerland (PRWEB) February 27, 2014 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today it will host a free webinar to educate scientists and researchers about the SURE CHO-Mplus™ Libraries to...

2014-02-26 23:03:59

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced two senior appointments to further strengthen its global biologics business. Somerset, NJ (PRWEB) February 26, 2014 Andrew Sandford joins Catalent as Vice President, Business Development, Biologics, and will focus on growth of the company’s existing biologics offerings, including the recently completed...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related